📣 VC round data is live. Check it out!
- Public Comps
- Inspire Medical Systems
Inspire Medical Systems Valuation Multiples
Discover revenue and EBITDA valuation multiples for Inspire Medical Systems and similar public comparables like Medartis, Shinva, Alphatec Holdings, Avanos Medical and more.
Inspire Medical Systems Overview
About Inspire Medical Systems
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
Founded
2007
HQ

Employees
1.3K
Website
Financials (LTM)
EV
$971M
Valuation Multiples
Start free trialInspire Medical Systems Financials
Inspire Medical Systems reported last 12-month revenue of $886M and EBITDA of $192M.
In the same LTM period, Inspire Medical Systems generated $758M in gross profit, $192M in EBITDA, and $100M in net income.
Revenue (LTM)
Inspire Medical Systems P&L
In the most recent fiscal year, Inspire Medical Systems reported revenue of $912M and EBITDA of $203M.
Inspire Medical Systems is profitable as of last fiscal year, with gross margin of 85%, EBITDA margin of 22%, and net margin of 16%.
Financial data powered by Morningstar, Inc.
Inspire Medical Systems Stock Performance
Inspire Medical Systems has current market cap of $1B, and enterprise value of $971M.
Market Cap Evolution
Inspire Medical Systems' stock price is $42.53.
Inspire Medical Systems share price decreased by 24.2% in the last 30 days, and by 69.2% in the last year.
Inspire Medical Systems has an EPS (earnings per share) of $5.05.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $971M | $1B | 1.7% | -24.2% | -34.1% | -69.2% | $5.05 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialInspire Medical Systems Valuation Multiples
Inspire Medical Systems trades at 1.1x EV/Revenue multiple, and 5.1x EV/EBITDA.
EV / Revenue (LTM)
Inspire Medical Systems Financial Valuation Multiples
As of May 20, 2026, Inspire Medical Systems has market cap of $1B and EV of $971M.
Inspire Medical Systems has a P/E ratio of 12.3x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Inspire Medical Systems Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Inspire Medical Systems Margins & Growth Rates
Inspire Medical Systems decreased revenue by 8% and EBITDA by 14% in the last fiscal year.
In the most recent fiscal year, Inspire Medical Systems reported gross margin of 85%, EBITDA margin of 22%, and net margin of 16%.
Inspire Medical Systems Margins
Inspire Medical Systems Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Inspire Medical Systems Operational KPIs
Inspire Medical Systems' revenue per employee in the last FY averaged $0.7M, while opex per employee averaged $0.5M for the same period.
Inspire Medical Systems' Rule of 40 is 13% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Inspire Medical Systems' Rule of X is 2% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Inspire Medical Systems Competitors
Inspire Medical Systems competitors include Medartis, Shinva, Alphatec Holdings, Avanos Medical, Arcs Co, SKAN Group, Integra Lifesciences, iRadimed, Shanghai Haohai and El.En. Group.
Most Inspire Medical Systems public comparables operate across Medical Devices, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 4.0x | 3.7x | 23.5x | 21.8x | |||
| 0.6x | — | 7.2x | — | |||
| 2.3x | 2.1x | 18.5x | 15.8x | |||
| 1.8x | 1.7x | 14.2x | 13.9x | |||
| 0.2x | 0.2x | 4.5x | 4.3x | |||
| 3.2x | 3.0x | 27.9x | 24.1x | |||
| 1.8x | 1.8x | 9.2x | 9.0x | |||
| 12.7x | 12.3x | 39.0x | 36.9x | |||
This data is available for Pro users. Sign up to see all Inspire Medical Systems competitors and their valuation data. Start Free Trial | ||||||
Inspire Medical Systems Funding History
Before going public, Inspire Medical Systems raised $80M in total equity funding, across 3 rounds.
Inspire Medical Systems Funding Rounds
Inspire Medical Systems Investment Activity
Inspire Medical Systems has invested in 2 companies to date.
Latest investment by Inspire Medical Systems was on June 25th 2025. Inspire Medical Systems invested in EnsoData in their $20M Series B round (EV/Revenue multiple of ).
Latest Investments by Inspire Medical Systems
| Description | — | — | Ognomy is a virtual care platform based in Tel Aviv, Israel, specializing in end-to-end sleep apnea management. Launched in 2020, it connects patients with board-certified sleep physicians for remote consultations, home sleep testing kits, customized CPAP prescriptions, and ongoing therapy monitoring through its HIPAA-compliant app. The service partners with insurers like Aetna and has treated over 10,000 patients across the US. |
| HQ Country | |||
| HQ City | — | — | Buffalo, NY |
| Deal Date | 25 Jun 2025 | 27 Apr 2022 | 27 Apr 2022 |
| Round | Series B | Series A | Seed |
| Raised | $20M | $20M | $1M |
| Investors | Inspire Medical Systems; Questa Capital Management; Supermoon Capital; Venture Investors; Zetta Venture Partners | Colle Capital Partners; Frederick Robertson; HealthX Ventures; Inspire Medical Systems; Justin Mortara; M25; Supermoon Capital; Venture Investors; Zetta Venture Partners | Inspire Medical Systems; Launch NY |
| Valuation | undisclosed | undisclosed | $9M |
| EV/Revenue | |||
| EV/EBITDA | |||
This data is available for Pro users. Sign up to see all Inspire Medical Systems investments and their VC round multiples. Start Free Trial | |||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Inspire Medical Systems
| When was Inspire Medical Systems founded? | Inspire Medical Systems was founded in 2007. |
| Where is Inspire Medical Systems headquartered? | Inspire Medical Systems is headquartered in United States. |
| How many employees does Inspire Medical Systems have? | As of today, Inspire Medical Systems has over 1K employees. |
| Who is the CEO of Inspire Medical Systems? | Inspire Medical Systems' CEO is Timothy P. Herbert. |
| Is Inspire Medical Systems publicly listed? | Yes, Inspire Medical Systems is a public company listed on NYSE. |
| What is the stock symbol of Inspire Medical Systems? | Inspire Medical Systems trades under INSP ticker. |
| When did Inspire Medical Systems go public? | Inspire Medical Systems went public in 2018. |
| Who are competitors of Inspire Medical Systems? | Inspire Medical Systems main competitors include Medartis, Shinva, Alphatec Holdings, Avanos Medical, Arcs Co, SKAN Group, Integra Lifesciences, iRadimed, Shanghai Haohai, El.En. Group. |
| What is the current market cap of Inspire Medical Systems? | Inspire Medical Systems' current market cap is $1B. |
| What is the current revenue of Inspire Medical Systems? | Inspire Medical Systems' last 12 months revenue is $886M. |
| What is the current revenue growth of Inspire Medical Systems? | Inspire Medical Systems revenue growth (NTM/LTM) is (3%). |
| What is the current EV/Revenue multiple of Inspire Medical Systems? | Current revenue multiple of Inspire Medical Systems is 1.1x. |
| Is Inspire Medical Systems profitable? | Yes, Inspire Medical Systems is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Inspire Medical Systems? | Inspire Medical Systems' last 12 months EBITDA is $192M. |
| What is Inspire Medical Systems' EBITDA margin? | Inspire Medical Systems' last 12 months EBITDA margin is 22%. |
| What is the current EV/EBITDA multiple of Inspire Medical Systems? | Current EBITDA multiple of Inspire Medical Systems is 5.1x. |
| What is the current FCF of Inspire Medical Systems? | Inspire Medical Systems' last 12 months FCF is $165M. |
| What is Inspire Medical Systems' FCF margin? | Inspire Medical Systems' last 12 months FCF margin is 19%. |
| What is the current EV/FCF multiple of Inspire Medical Systems? | Current FCF multiple of Inspire Medical Systems is 5.9x. |
| How many companies Inspire Medical Systems has acquired to date? | Inspire Medical Systems hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Inspire Medical Systems has invested to date? | As of May 2026, Inspire Medical Systems has invested in 2 companies. |
| What was the last Inspire Medical Systems investment? | On 25th June 2025 Inspire Medical Systems invested in EnsoData, participating in a $20M Series B round, alongside Questa Capital Management, Supermoon Capital, Venture Investors, and Zetta Venture Partners. |
| In what companies Inspire Medical Systems invested in? | Inspire Medical Systems invested in EnsoData and Ognomy. |
See public comps similar to Inspire Medical Systems
Lists including Inspire Medical Systems
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
